Of note, the medications for type 2 diabetes which the participants were taking at baseline in this study were either metformin, sulfonylureas, thiazolidinediones or insulin (with an exception of only 2 participants taking alpha‐glucosidase inhibitors). The gene discussed is INS; the disease is type 2 diabetes mellitus.